Sotera Health Company

SHC

NASDAQ

Healthcare

Medical - Diagnostics & Research

Broadview Heights, OH, US3,000 employeessoterahealth.com

$14.97

+0.10(0.67%)

Mkt Cap $4.3B

$9.80

$19.35

52-Week Range

At a Glance

AI-generated

8-K

Sotera Health Company disclosed that Class I director Constantine S. Mihas will resign effective March 16, 2026, due to a reduction in stockholder-designated directors, with no disagreements on company matters. The Board appointed Kenneth D. Krause, former CFO of Rollins, Inc. and MSA Safety, as replacement Class I director effective the same date; he will serve on the Audit and Litigation Committees and is independent.

$4.3B

Market Cap

$1.2B

Revenue

$78M

Net Income

Employees3,000

Fundamentals

How The Business Makes Money

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Industry Medical - Diagnostics & Research

Activity

What Changed Recently

Management Change

Mar 15, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 12

Management Change

Feb 4, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February

Financial Results

Feb 23, 2026

, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the

Financial Results

Jan 11, 2026

and Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as

Other Event

Mar 5, 2026

Other Events On March 4, 2026, Sotera Health Company (the “Company”), certain stockholders named in Schedule 2 thereto (the “Selling Stockholders”) and Wells Fa

Peer Companies

Company	Price	Change	Market Cap	P/E
ACLXArcellx, Inc.	$114.77	+0.02%	$6.7B	-28.2
PTGXProtagonist Therapeutics,...	$103.85	+0.18%	$6.6B	-48.1
GKOSGlaukos Corporation	$112.49	-0.13%	$6.5B	-32.7
BLCOBausch + Lomb Corporation	$16.48	-1.20%	$5.8B	-15.6
ALKSAlkermes plc	$34.84	-0.58%	$5.8B	18.9
TFXTeleflex Incorporated	$117.81	-0.52%	$5.2B	-5.2
OPCHOption Care Health, Inc.	$27.43	+3.55%	$4.4B	21.6
MMSIMerit Medical Systems, In...	$67.66	-0.83%	$4.0B	31.5

Analyst View

Company Profile

CIK0001822479

ISINUS83601L1026

CUSIP83601L102

Phone440 262 1410

Address9100 South Hills Boulevard, Broadview Heights, OH, 44147, US

SEC EDGAR